Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists

Laura A. Solt, Yongjun Wang, Subhashis Banerjee, Travis Hughes, Douglas J. Kojetin, Thomas Lundasen, Youseung Shin, Jin Liu, Michael D. Cameron, Romain Noel, Seung Hee Yoo, Joseph S. Takahashi, Andrew A. Butler, Theodore M. Kamenecka, Thomas P. Burris

Research output: Contribution to journalArticlepeer-review

586 Scopus citations


Synchronizing rhythms of behaviour and metabolic processes is important for cardiovascular health and preventing metabolic diseases. The nuclear receptors REV-ERB-α and REV-ERB-β have an integral role in regulating the expression of core clock proteins driving rhythms in activity and metabolism. Here we describe the identification of potent synthetic REV-ERB agonists with in vivo activity. Administration of synthetic REV-ERB ligands alters circadian behaviour and the circadian pattern of core clock gene expression in the hypothalami of mice. The circadian pattern of expression of an array of metabolic genes in the liver, skeletal muscle and adipose tissue was also altered, resulting in increased energy expenditure. Treatment of diet-induced obese mice with a REV-ERB agonist decreased obesity by reducing fat mass and markedly improving dyslipidaemia and hyperglycaemia. These results indicate that synthetic REV-ERB ligands that pharmacologically target the circadian rhythm may be beneficial in the treatment of sleep disorders as well as metabolic diseases.

Original languageEnglish (US)
Pages (from-to)62-68
Number of pages7
Issue number7396
StatePublished - May 3 2012
Externally publishedYes

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists'. Together they form a unique fingerprint.

Cite this